Carrez; Chantal

Patent Applications and Registrations

Patent applications and USPTO patent grants for Carrez; Chantal.The latest application filed is for "anti-cd3 antibodies, anti-cd123 antibodies and bispecific antibodies specifically binding to cd3 and/or cd123".

Company Profile

1.6.12

Carrez; Chantal - Thiais FR
Carrez; Chantal - Paris FR
Carrez; Chantal - Thias FR
Carrez; Chantal - Thais FR

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Anti-cd3 Antibodies, Anti-cd123 Antibodies And Bispecific Antibodies Specifically Binding To Cd3 And/or Cd123 App 20210292423 - Albrecht; Jana ; et al.	2021-09-23
Anti-CD3 antibodies, anti-CD123 antibodies and bispecific antibodies specifically binding to CD3 and/or CD123 Grant 10,906,978 - Albrecht , et al. February 2, 2	2021-02-02
Anti-cd3 Antibodies, Anti-cd123 Antibodies And Bispecific Antibodies Specifically Binding To Cd3 And/or Cd123 App 20180222987 - Albrecht; Jana ; et al.	2018-08-09
Anti-cd3 Antibodies, Anti-cd123 Antibodies And Bispecific Antibodies Specifically Binding To Cd3 And/or Cd123 App 20180057597 - ALBRECHT; Jana ; et al.	2018-03-01
Combination Therapy For The Treatment Of Cd19+ B-cell Malignancies Symptoms Comprising An Anti-cd1 Maytansinoid Immunoconjugate And Rituzimab App 20140199300 - Besret; Laurent ; et al.	2014-07-17
Isoindole derivatives, compositions containing same, preparation thereof and pharmaceutical uses thereof in particular as inhibitors of chaperone protein Hsp90 activities Grant 8,034,939 - Mailliet , et al. October 11, 2	2011-10-11
Azaindoles for inhibiting aurora2 and other kinases Grant 7,943,616 - Cox , et al. May 17, 2	2011-05-17
Fluorene derivatives, composition containing said derivatives and the use thereof Grant 7,674,795 - Mailliet , et al. March 9, 2	2010-03-09
Novel Fluorene Derivatives, Composition Containing Said Derivatives and the Use Thereof App 20080153837 - MAILLIET; Patrick ; et al.	2008-06-26
Purine Derivatives, Compositions Containing Them and Use Thereof App 20080119467 - CARREZ; Chantal ; et al.	2008-05-22
Novel Isoindole Derivatives, Compositions Containing Same, Preparation Thereof and Pharmaceutical Uses Thereof in Particular as Inhibitors of Chaperone Protein HSP90 Activities App 20080119507 - MAILLIET; Patrick ; et al.	2008-05-22
Use of Purine Derivatives as HSP90 Protein Inhibitors App 20080108612 - CARREZ; Chantal ; et al.	2008-05-08
Novel 3-Aryl-1,2-Benzisoxazole Derivatives and Use Thereof as Medicinal Products Against Cancer App 20080070960 - BERTIN; Luc ; et al.	2008-03-20
Substituted benzimidazole compounds and their use for the treatment of cancer Grant 7,041,668 - Clerc , et al. May 9, 2	2006-05-09
Azaindoles App 20050267304 - Cox, Paul J. ; et al.	2005-12-01
Azaindoles Grant 6,897,207 - Cox , et al. May 24, 2	2005-05-24
Substituted benzimidazole compounds and their use for the treatment of cancer App 20050014811 - Clerc, Francois ; et al.	2005-01-20
Azaindoles App 20040053931 - Cox, Paul J. ; et al.	2004-03-18

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.